Speculating in Takeover Targets Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets

ULBI 8.860

-1.6%

9:40 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: richardred who wrote (4308)	1/11/2017 8:18:17 AM
From: richardred	Read Replies (2) of 7120

Eleven days into the new year and a Bullseye Today- DSCI BRIEF-Integra Lifesciences to buy Derma Sciences * Derma Sciences to be acquired by Integra Lifesciences for $7.00 per share of common stock in cash * Says will be acquired by Integra Lifesciences Holdings Corporation for $7.00 per share of common stock in cash * Says deal for a total of approximately $204 million * Says Integra will also assume contingent liabilities related to biod transaction * Says q4 net sales of $26.9 million * Says q4 awc net sales of $20.3 million representing growth of 95.6% Source text for Eikon: Further company coverage: P.S. Message 30855045

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next